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Abstract
Background: Exercise therapy has long been used for rehabilitation purposes after myocardial infarction (MI) and
the benefit of regular physical exercise is also well-established. High-intensity interval training (HIIT) has been proposed
to be more effective than continuous exercise for improving exercise capacity and health-related adaptations to
low-volume (LV) and HIIT are also known. Furthermore, the Mediterranean diet (Mediet) has been widely reported
to be a model of healthy eating for its contribution to a favorable health status and a better quality of life, reducing
overall mortality. This study will investigate the effects of different HIIT programs (high-volume [HV] vs LV) and Mediet
recommendations in clinical condition, cardiorespiratory fitness, biomarkers, ventricular function, and perception
of quality of life after MI, and compared to an attention control group that is recommended to Mediet and physical
activity without supervision sessions.
Methods/Design: In this randomized controlled trial, cardiorespiratory fitness, anthropometry, central and peripheral
cardiovascular variables, biochemical and nutritional condition, and quality of life will be assessed before and after 16
weeks of intervention in 177 participants diagnosed with MI type 1. All participants will be randomly (1:1:1) assigned to
the attention control group or two exercise groups (Mediet recommendations plus supervised aerobic exercise two
days/week: (1) HV (40 min) HIIT group and (2) LV (20 min) HIIT group.
Discussion: This study will be the first clinical trial comparing the effects of two different volumes of HIIT programs
with Mediet recommendations for people after MI. The results of this study will provide good evidence for physical
rehabilitation in this population.
Trial registration: ClinicalTrials.gov, NCT02876952. Registered on 24 August 2016.
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Background
The term “myocardial infarction” (MI) may have
major psychological and legal implications for the in-
dividual and society. It remains the principal cause of
death and disability worldwide and is a measured out-
come in clinical trials [1]. Hence, coronary heart dis-
ease is a chronic condition and patients are at high
risk for new events and premature death. Several
evidence-based interventions can improve prognosis.
Thus, lifestyle changes should be explained and pro-
posed to the patients before discharge, including ces-
sation of smoking, blood pressure (BP) control, advice
regarding diet and weight control, and the encourage-
ment of physical activity. Exercise therapy has long
been used for rehabilitation purposes and the benefit
of regular physical exercise is also well-established
[2]. It is known that exercise can improve both car-
diovascular and non-cardiovascular parameters, such
as improved anxiety, patient self-confidence, endothe-
lial function, exercise capacity, cardiovascular effi-
ciency, reduction in atherogenic and thrombotic risk
factors, and perception of wellbeing have been de-
scribed [2–6]; it is also included as an essential com-
ponent for secondary prevention [7]. Furthermore, the
risks of a well-designed supervised exercise program
are very low [2, 8]. The intensity of aerobic exercise
training is a key issue in cardiac rehabilitation pro-
grams [9]. Intensity ranges for aerobic training pre-
scription and design are included in several guidelines
and publications regarding secondary prevention and
cardiac rehabilitation [9, 10]. Aerobic fitness is recog-
nized as a robust indicator of cardiovascular health
and a well-established predictor of total and car-
diovascular mortality in people with and without cor-
onary heart disease. Direct measurements of peak
oxygen uptake (VO2peak) and ventilatory thresholds
(i.e. VT1 and VT2) are considered the gold standard
references for the evaluation of aerobic metabolism
function and, consequently, for aerobic exercise in-
tensity assessment and design [9, 11]. The increase of
VO2peak and VTs after a period of exercise training
depends on the components of the FITT principle
(i.e. frequency, intensity, time or volume, and type or
modality), which constitute the key to achieve a safe
exercise training effect. Endurance aerobic training is typ-
ically performed as continuous training at moderate-to-
high exercise intensity in steady-state conditions of aer-
obic energetic yield. However, high-intensity interval
training (HIIT) (i.e. repeated bouts of short duration,
high- to severe- or severe- to extreme-intensity exer-
cise, separated by brief periods of lower intensity) has
been proposed to be more effective than continuous
exercise for improving exercise capacity [9, 12–16].
Adding to that, health-related adaptations to low-
volume and high-intensity interval training (LV-HIIT)
have been presented. This type of training is character-
ized by sessions that involve a relatively small total
amount of exercise at high intensity (i.e. ≤ 10 min) [17].
Previous studies have shown that LV-HIIT is an effect-
ive and time-efficient training strategy for improving
insulin sensitivity, glucose control, and biomarkers of
vascular function [18] and that training-induced adap-
tation for high-volume (HV) moderate-intensity con-
tinuous exercise and LV-HIIT protocols are strikingly
similar [19]. Although contradictory results of the effect
of HIIT in cardiovascular patients have been previously
presented [20], to our knowledge there are no studies
that compare HIIT with different volume exercise in a
population that has suffered MI and compare that to an
attention control group (AC) who is receiving only
physical activity recommendations.
On the other hand, the relevance of overall high-
quality food patterns, rather than focus on single nutri-
ents and foods, has emerged as a powerful paradigm to
address the diet and to assess their potential cardiovas-
cular disease preventative effects [21]. The Mediterra-
nean diet (Mediet), representing the dietary pattern
usually consumed among the populations bordering the
Mediterranean Sea, has been widely reported to be a
model of healthy eating for its contribution to a favor-
able health status and a better quality of life, reducing
overall mortality from cardiovascular diseases [22].
Considering all the above-mentioned points, the
INTERFARCT study is designed to investigate what effect
different 16-week supervised aerobic INTERval exercise
programs (HV vs LV) with Mediet recommendations will
have in people after suffering an acute myocardial
inFARCTion compared to AC that is recommended a
Mediet and physical activity without supervision sessions.
We hypothesize that: (1) supervised HIIT will get
superior improvements in cardiovascular health than
only physical activity recommendations; and (2) a high-
intensity and LV exercise program will get similar re-
sults compared to a high-intensity and HV exercise
program. Therefore, the primary objective of this ran-
domized controlled trial (RCT) will be to assess the
effects of different programs of HIIT and Mediet rec-
ommendations on overall health, cardiorespiratory fit-
ness, biomarkers, ventricular function, and perception
of quality of life after MI compared to only physical ac-
tivity recommendations. The secondary objectives will
be: (1) to analyze the differences in the studied vari-
ables between the two HIIT programs (HV vs LV) with
Mediet recommendations to observe the effect of exer-
cise volume; and (2) to analyze whether a treatment
with only recommendations (exercise and diet) is ef-
fective in the secondary prevention of cardiovascular
disease compared to supervised exercise.
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Methods/design
Study design
INTERFARCT is a prospective, open-label, blinded-
endpoint, three-arm, parallel RCT (ClinicalTrials.gov ID:
NCT02876952) and fulfills the requirements of the Stan-
dard Protocol Items: Recommendations for Interventional
Trials (SPIRIT) checklist [23] (Additional file 1). The
Ethics Committee of the University of the Basque
Country (UPV/EHU, CEISH, 2016) and the Ethics
Committee of Clinical Investigation of Burgos Univer-
sity Hospital (CEIC 1462) have approved the study de-
sign, protocol, and informed consent procedure. All
participants have to provide written informed consent
before the clinical and physiological examination. Each
participant will be given the opportunity to ask ques-
tions about the involvement in the trial and to have
those questions answered by a researcher associated
with the trial before providing consent. After baseline
measurements, the participants will be followed for 16
weeks. All follow-up examinations will be performed in
the same laboratory setting and by the same researchers
as in the baseline measurements. After baseline testing,
they will be enrolled in the trial given a trial-specific
identification (i.e. INTERFARCT-1) number (ID). Allo-
cation consignment was performed by one of the exer-
cise physiologists who was not involved in the
recruitment process. The participants were randomized
to one of the three intervention groups (Attention Control
[AC], HV High-Intensity Interval Training [HV-HIIT], or
LV-HIIT) stratified by sex, body mass index (BMI), and
age using a block and stratified randomization method
and with a randomization ratio of 1:1:1. Medical staff will
be blinded to participant randomization assignment. The
trial will be conducted in the Cardiology Department at
Santiago Apóstol Hospital, Miranda de Ebro, Burgos,
Spain. A trial-specific ID number will be used when gath-
ering and recording information about a participant. A list
containing the contact details of all participants and their
corresponding ID numbers will be kept separate from all
other data. All paper copy forms will be stored in a locked
cabinet in the hospital facility during the trial and only re-
searchers involved in the trial will have access. Study data
will be accessible by the researchers involved in the trial
and only the principal investigator and investigators in the
project will have access to data analysis.
Participants and selection criteria
The population will include 177 participants (men and
women) with the diagnosis of MI according to criteria
of “Third Universal definition of myocardial infarction”
and clinical classification of MI type 1, called “Spontan-
eous myocardial infarction” [1], recruited from the car-
diology services by the physician specialists. In turn,
before testing protocol begins, an ergometry is performed
according to the clinical history for participants’ screening
to ensure there is no ongoing myocardial ischemia. After
completion of the informed consent process, clinical his-
tory, blood sample for baseline analysis, electrocardio-
gram, and echocardiogram are obtained from all
participants to evaluate the eligibility criteria. Only partici-
pants who have been managed with revascularization are
included. The inclusion and exclusion criteria for the
INTERFARCT study are shown in Table 1. After assess-
ment for eligibility and consent, different clinical research
members collect the baseline data necessary to complete
the pre-randomization information.
Measurements
The measurements used in the protocol will be taken
before and after the intervention period (16 weeks).
The study protocol flow of participants is outlined in
Fig. 1. The post-intervention test will be scheduled
the following week after finishing the 16-week inter-
vention period. The primary outcome variable is car-
diorespiratory fitness, measured through VO2peak. The
Table 1 Inclusion and exclusion criteria for the INTERFARCT study
Inclusion criteria
- MI type I: Spontaneous MI [1], with and without ST elevation
- Effective revascularization treatment (coronary artery bypass grafting
or percutaneous coronary intervention)
- Age ≥ 18 years, clinically stable on sinus rhythm
- Between six months and two years after the MI
- Left ventricular ejection fraction > 50%
- Time availability (45 min, two days a week for 16 weeks) to carry out
the exercise program
Exclusion criteria
- Unstable coronary artery disease, uncontrolled hypertension,
malignant ventricular arrhythmia, atrial fibrillation, exercise-induced
ischemia, and ventricular failure during exercise
- Other significant medical conditions including, but not limited to:
chronic or recurrent respiratory, gastrointestinal, neuromuscular,
neurological, or psychiatric conditions; musculoskeletal problems
interfering with exercise; severe kidney disease (creatinine clearance
< 30 mL/min, calculated in accordance with Modification of Diet in
Renal Disease equation [MDRD]), autoimmune or collagen vascular
diseases; immunodeficiency diseases or a positive human
immunodeficiency virus test; anemia (hemoglobin < 12 g/dL),
bleeding disorders, chronic thrombotic disorders, or
hypercoagulable states; malignancies in the past five years, with the
exception of skin cancer therapeutically controlled; endocrine and
metabolic disorders, including type 1 diabetes; moderate to severe
peripheral artery disease (> IIa in Fontaine’s classification); any other
medical condition or disease that is life-threatening or that can
interfere with or be aggravated by exercise
- Any other co-morbidity with life expectancy < 1 year
- Could not perform a valid baseline exercise test
- Obesity > 35 kg/m2
- Pregnancy or breastfeeding
- Plans to be out of the city > 2 weeks
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secondary outcome variables include left ventricular
function, body composition, biochemical profile, vas-
cular endothelial function, dietary adherence, the state
of depression and anxiety, and health-related quality
of life. The SPIRIT figure showing the respective time
points for assessments and intervention is provided in
Fig. 2.
Anthropometry and body composition
Anthropometry includes stature (SECA 213), total body
mass (SECA 869), BMI calculated as (total body mass
[kg]/stature [m2]), and waist and hip circumferences
(SECA 200) to calculate waist:hip ratio. All measure-
ments will be taken in accordance with guidelines from
the International Society for the Advancement of
Kinanthropometry [24]. Furthermore, fat-free mass,
total body water, and fat mass will be estimated with
bioelectrical impedance analysis (Tanita, BF 350 and
Tanita, BC-418 MA).
Lifestyle and health behavior
Participants’ health-related quality of life will be deter-
mined using the 36-item Short Form Medical Outcome
Questionnaire (SF-36) [25]. It is a 36-item questionnaire
that measures eight multi-item dimensions of health:
physical functioning; social functioning; role limitations
due to physical problems; role limitations due to emo-
tional problems; mental health; energy/vitality; body
pain; and general health perception. Scores will be
coded, summed, and converted into a scale from 0
(worst possible health state) to 100 (best possible health
state) for each dimension item.
Anxiety and depression levels will be assessed
through the Spanish version of the Hospital Anxiety
and Depression Scale (HADS), which is a 14-item self-
report screening scale. The HADS consists of a seven-
item anxiety subscale and a seven-item depression
subscale. Each item scores on a 4-point Likert scale [26].
Cardiovascular measurements at rest
A 12-lead electrocardiogram, left ventricular function
by echocardiography, flow-mediated dilation (FMD),
and carotid intimae media thickness (CIMT) by ultra-
sound scanning will be the methods used to assess cen-
tral and peripheral cardiovascular variables.
Echocardiography will be performed by two experi-
enced cardiologists blinded to the participant’s group as-
signment. The average of these two measurements will
be used in the statistical analysis [27]. Participants will
be examined at rest using an ultrasound system (GE
Healthcare, Vivid 9) according to standard procedures
for evaluated left ventricle dimensions and diastolic and
Fig. 1 Planned flow diagram of the INTERFARCT study from recruitment to the end of the intervention
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systolic functions [27]. Left ventricle end-diastolic
diameter, diastolic and systolic volumes, and ventricular
mass will be measured and indexed to body surface
area. Assessment of left ventricle diastolic function will
include peak early (E) and late (A) diastolic mitral in-
flow velocities, early deceleration time (EDT), early dia-
stolic tissue Doppler velocity (e’), and E/e’ ratio. On the
other hand, determination of left ventricle systolic func-
tion will be carried out by calculation of biplane ejec-
tion fraction (Simpson’s rule), cardiac output (CO), and
determination of peak annulus velocity in systole (S′).
For each participant, microvascular and conduit
artery function in the forearm will be assessed with
non-invasive, high-resolution ultrasonography of the
brachial artery, using a handheld ultrasound probe.
Flow-mediated dilation, a biomarker for endothelial
function, will be evaluated with high-resolution ultra-
sonography and performed following the International
Brachial Artery Reactivity Task Force guidelines using a
2.5- to 13-MHz linear array transducer (GE Healthcare,
Vivid 7) with a stereotactic probe-holding device. Con-
duit artery function will be assessed of FMD (endothe-
lium-dependent response) and nitroglycerin-mediated
dilation (endothelium-independent response) [28–30].
Carotid intima-media thickness (GE Healthcare, Vivid
7) will be carried out by two sonographers blinded to
the intervention’s groups assignment. For each individ-
ual, mean CIMT will be defined as the average of all six
segments intima-media thickness measurements in
each carotid artery [31, 32]. The image analyses will be
Fig. 2 SPIRIT figure showing an overview of the assessment schedule at baseline and follow-up in the INTERFARCT study. IPAQ International Phys-
ical Activity Questionnaire, ECG electrocardiogram, MSWT Modified Shuttle Walking Test, CPET cardiopulmonary exercise test
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performed with validated software (eTRACK) [33] and
all ultrasonographic measures will be analyzed by an-
other blind specialist.
Physical fitness
Physical fitness will include the Modified Shuttle Walk-
ing Test (MSWT) and a peak, symptom-limited cardio-
pulmonary exercise test (CPET). The two tests will be
conducted on different days. The purpose of doing a
CPET and MSWT will be to evaluate the exercise re-
sponses in both physical activity modalities (i.e. walking/
running and biking).
The MSWT requires the participant to walk up and
down a 10-m course and it will be performed as previ-
ously described by Singh et al. [34]. Participants will
walk along a flat, indoor 10-m course marked by two
cones placed 0.5 m in from each end of the course. A
shuttle will refer to one 10-m lap. Standardized prere-
corded instructions for the test will be played from a
digital recording immediately before beginning the test.
The test will be externally paced, with signal beeps at
regular intervals to indicate when the participant should
be turning around the cone to commence the next shut-
tle. A triple beep will signal the next level and an in-
crease in walking speed. Participants will commence the
test at a walking speed of 0.5 m/s (level 1), allowing the
participant 20 s to complete each of the three shuttles in
level 1. There will be a speed increment of 0.17 m/s each
minute for a maximum of 15 min. The test will be
stopped when the participant can no longer maintain
the required pace or is > 0.5 m from the cone before the
signal beep after one opportunity to catch up or if the
test is completed. Additional criteria for early termin-
ation of the test will include patient distress, dizziness,
angina, or onset of severe musculoskeletal pain, failure
of the heart rate (HR) to increase with exercise or attain-
ment of 85% of the maximum HR (estimation by sub-
tracting the person’s age from 220). The number of
shuttles completed will be recorded at the completion of
each test and converted to the distance walked. Before
commencing the test, with the participant in a seated
position, baseline HR and BP will be recorded. HR and
Borg scale (scale of 6–20) will be monitored throughout
the test; BP and HR continue to be recorded a further 5
min after completion of the test [35, 36].
The CPET will be performed in the upright position
on an electronically braked Lode Excalibur Sport Cycle
Ergometer (Groningen, The Netherlands). Testing proto-
col will start at 0 W with gradual increments of 10 W
every minute to exhaustion with continuous ECG moni-
toring. The test will not be preceded by any type of
warm-up and the participant will cycle at least 70 rpm.
The expired gas analysis will be conducted using a com-
mercially available system (Ergo CardMedi-soft S.S,
Belgium Ref. USM001 V1.0) that will be calibrated be-
fore each test session with a standard gas of known con-
centration and volume. Breath-by-breath gas exchange
data will be measured continuously during exercise and
averaged every 60 s. Peak oxygen uptake will be defined
as the highest oxygen uptake (VO2peak) value attained
toward the end of the test. Achievement of true peak ef-
fort will be assumed in the presence of two or more of
the following criteria: (1) volitional fatigue (> 18 on the
BORG scale); (2) peak respiratory exchange ratio
(VCO2/VO2) ≥ 1.1; (3) achieving > 85% of age-predicted
HRmax; and (4) failure of VO2 and/or HR to increase
with further increases in work rate [9]. A self-reported
Borg rating of perceived exertion (scale of 6–20) will be
recorded at the end of each stage. BP will be measured
every 2 min throughout the test. Ventilatory thresholds
(i.e. VT1 and VT2) will be assessed by standardized
methods using the V-slope and ventilatory equivalents.
The first ventilatory threshold (VT1) will be identified as
the point of transition in the carbon dioxide production
(VCO2) vs VO2 slope from < 1 to > 1, or VT1 will also
be identified as the nadir of the ventilatory equivalent
(VE) of VO2 vs work rate relationship. The second venti-
latory threshold (VT2) will be identifiable as the nadir of
the VE/VCO2 vs work rate relationship. [9] After com-
pletion of the test, participants will remain on the bike
for a further 5 min for recovery with an electrocardio-
gram (ECG) and BP monitoring. Absolute and relative
indications for terminating the exercise test will be taken
into account [37]. The identification of the two VT will
determine the three different exercise intensity domains
or ranges for exercise design (R1, R2, R3): (R1) light to
moderate exercise intensity with HR values below VT1;
(R2) moderate to high or vigorous exercise intensity with
HR values between VT1 and VT2; and (R3) high to se-
vere exercise intensity with HR values up to VT2 to peak
intensity. When it is not possible to identify the VT2, ex-
ercise intensity domains will be established taking into
account percentages of HR reserve, i.e. moderate inten-
sity is defined as 65–75% of HR reserve, high intensity
from ≥ 85% to < 95% of HR reserve [9].
Biochemical profile
Morning fasting blood samples will be obtained from
each participant by experienced nursing staff at the
Santiago Apóstol Hospital (Miranda de Ebro, Burgos).
This procedure will permit measurements of general
metabolism (renal function: urea [mg/dL], creatinine
[mg/dL], glomerular filtration rate [mL/ min/body sur-
face area]; carbohydrates metabolism: basal glucose [mg/
dL], HbA1c [%], fasting insulinemia [μUI/mL], homeo-
static model assessment to quantify insulin resistance,
HOmeostatic Model Assessment-Insulin Resistance [in-
sulin (μU/L) × glucose (mmol/L)/22.5]; hepatic function:
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aspartate transaminase [U/L], alanine transaminase [U/
L], alkaline phosphatase [U/L]; blood cells: hemoglobin
[g/dL], hematocrit [%], leukocytes [/uL], lymphocytes
[/uL], neutrophils [/uL], and platelets [/uL]), lipid me-
tabolism (total cholesterol [mg/dL], low-density lipopro-
tein cholesterol [mg/dL], high-density lipoprotein
cholesterol [mg/dL], triglycerides [mg/dL]; oxidative
stress: ox-LDL [U/dL]), muscular and myocardial stress
(troponin T [μg/L]; total creatine kinase [U/L]; pro-b-
type natriuretic peptide [pg/mL]), systemic inflammation
(highly sensitive C-reactive protein [mg/L], interleukin-6
[pg/mL], tumor necrosis factor-alpha [pg/mL]) and pro-
coagulant state (D-dimer [ng/mL], fibrinogen [mg/dL]).
Mediterranean diet pattern
The dietary habits of participants will be assessed using
a validated 137-item food frequency questionnaire (FFQ)
including eight items related to seafood [38] and a 24-h
recall questionnaire. A trained nurse in face-to-face in-
terviews and group counseling will complete the FFQ.
Nutrient intakes will be computed using Spanish food
composition Tables [39]. The Mediet adherence is evalu-
ated through a 14-item Mediterranean Diet Adherence
Screener (MEDAS), which consists of 12 questions on
food consumption frequency and two questions on food
intake habits considered characteristics of the Spanish
Mediterranean diet [40]. Participants will receive the
main dietary recommendations included in the PRE-
DIMED trial [21, 41]. The major characteristics of this
diet are: (1) a high consumption of cereals, legumes,
nuts, vegetables, and fruits; (2) a relatively high-fat con-
sumption, mostly provided by olive oil; (3) moderate to
high fish consumption; (4) poultry and dairy products
consumed in moderate to small amounts; (5) low con-
sumption of red meats and meat products; and (6) moder-
ate alcohol intake, usually in the form of red wine [42, 43].
Participants will be encouraged, weighed, and receive ad-
vice and nutritional counseling every two weeks to help in
their compliance with the dietary recommendations and
requirements.
Intervention/attention control
The AC group will receive Mediet and regular physical
exercise recommendations to keep ethical procedures
regarding health. In this sense, participants will be ad-
vised to participate, without supervision, in at least 30
min of moderate-intensity dynamic aerobic exercise
(walking, jogging, cycling, or swimming) 5–7 days per
week [13, 44]. Participants will receive information re-
lated to HR values regarding moderate exercise inten-
sity domains for the self-monitoring of exercise
intensity and will be encouraged to keep a daily record
of the performed physical activity.
Exercise groups will receive Mediet recommendations
and supervised exercise:
(1) HV-HIIT group: high-intensity (HR values up to
VT2 to peak intensity or ≥ 85% to < 95% of HR
reserve) interval training and HV increasing
gradually from 20 min to 40 min and alternating
high and moderate intensities at different
protocols; and
(2) LV-HIIT group: HIIT and low-volume (20 min)
alternating high and moderate intensities at
different protocols.
Exercise intervention program
The participants in the HIIT groups will exercise two
non-consecutive days per week for 16 weeks under
supervision by an exercise specialist and we will also re-
quest to continue with their normal activity patterns
outside of the study protocol. All the exercises sessions
will start and finish with BP monitoring; training inten-
sity will be controlled by HR monitoring (Polar Electro,
Kempele, Finland) and through the rate of perceived ex-
ertion using the Borg’s original scale (6–20 points). Each
session will include a 10-min warm-up with joint mobil-
ity (i.e. starting at the top of the body and working the
way down, from the neck, shoulders, upper back, hips,
and ankles) with continuous leg movement to facilitate
the venous return and coordination exercises (e.g. toe-
tapping arm circles, heel walks, high knee walk, backwards
high knee skip) and a 10-min cool-down period with pas-
sive stretching exercises on the floor to ensure a progres-
sive return to the resting values of both HR and BP. The
main portion of the training session will consist of aerobic
exercises (i.e. one day of the week on the treadmill and the
second one on the bike) developing progressively both the
volume (i.e. 20 min to 40 min in HV-HIIT, whereas in LV-
HIIT the duration will always be 20 min) and intensity.
The rationale of mixing bike and treadmill will be to avoid
the osteoarticular impact of two treadmill days taking into
account the HIIT program. Intensity will be individually
tailored to HR at moderate or vigorous intensities, adjust-
ing the speed and incline of the treadmill or the power
and speed on the bike to achieve the planned target HR
(Table 2). The importance of targeting moderate and high
intensity will be emphasized.
Several strategies will be implemented to maximize ad-
herence, including music in all sessions, individualized
attention at the intervention sessions, and telephone
calls following missed sessions.
High-intensity interval training protocol on the treadmill
The high intensity aerobic exercise groups will carry out
a 5- to 10-min warm-up period at a moderate-intensity
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(i.e. HR values between VT1 and VT2 or 65–75% of HR
reserve) on the treadmill, before walking two intervals of
4 min at high intensity (i.e. HR values up to VT2 to peak
intensity or ≥ 85% to < 95% of HR reserve). The partici-
pants will exercise at the lower-intensity limit for the
first two weeks of the training period before increasing
the intensity towards the upper limit. Between the high-
intensity intervals, 3 min of walking at moderate inten-
sity will be conducted. The training session will end with
a 4-min cool-down period at moderate intensity. This is
a traditional protocol in cardiac rehabilitation programs
and research with cardiac patients [15, 45]. This will give
a total exercise time of 20 min. While this protocol will
be kept in the LV-HIIT group, every two weeks the HV-
HIIT will progress to four intervals of 4 min at high in-
tensity and 40 min of total volume (Table 2).
High-intensity interval training protocol on the bike
The high-intensity aerobic exercise groups will carry out
a 5- to 10-min warm-up period on the bike. After that,
the participant will cycle for 30 s at high intensity (i.e.
HR values up to VT2 to peak intensity or ≥ 85% to <
95% of HR reserve) followed by 60 s at moderate inten-
sity (i.e. HR values between VT1 and VT2 or 65–75% of
HR reserve) [46]. Four repetitions (1 rep = 30 s high in-
tensity followed by 60 s moderate intensity) will be ini-
tially performed in both groups and gradually increased
to 16 repetitions in the HV group, while eight repetitions
will be completed (Table 2) in the LV group. The train-
ing session will end with a 4- to 7-min cool-down period
at moderate intensity. The protocol design for biking has
already been established in cardiac rehabilitation pro-
grams [14].
Participant withdrawal
A participant could leave the study at any time. When
withdrawing from the study, the participant should let
the research team know that he/she wishes to withdraw.
The following are the trial-related reasons for the par-
ticipant to be discontinued from the trial by the princi-
pal investigator: (1) failure to maintain 80% compliance
to exercise training sessions or even the last four weeks
(minimum eight sessions), to avoid detraining; (2) more
than two consecutive weeks without training, to avoid
detraining; (3) participant’s condition or disease pro-
gresses; (4) participant experiences a serious adverse
event (e.g. angina, dyspnea, light-headedness) [47] that
requires discontinuation or withdrawal from the study
according to the study protocol; or (5) pregnancy.
Data analysis
The primary outcome variable of this study is VO2peak.
A priori power analysis (G*Power 3 statistical software)
[48] was performed to calculate the average sample size.
Due to the lack of any source on the effect of VO2peak in
MI patients, we speculate a similar increase based on a
Table 2 Intervention program for high-volume high-intensity (HV-HIIT) and low-volume high-intensity (LV-HIIT) groups on the tread-
mill and the bike. Volume and intensity progression
High-intensity interval Moderate-intensity interval High-intensity interval Moderate-intensity interval
HV-HIIT treadmill LV-HIIT treadmill
Weeks Volume (min) Intensity (%HRres) Volume (min) Intensity (%HRres) Volume (min) Intensity (%HRres) Volume (min) Intensity (%HRres)
1–2 8 85 12 65 8 85 12 65
3–4 12 85 13 65 8 85 12 65
5–6 16 90 14 70 8 90 12 70
7–8 16 90 19 70 8 90 12 70
9–10 16 95 24 75 8 95 12 75
11–12 16 95 24 75 8 95 12 75
13–16 16 95 24 75 8 95 12 75
HV-HIIT bike LV-HIIT bike
Weeks Volume (min) Intensity (%HRres) Volume (min) Intensity (%HRres) Volume (min) Intensity (%HRres) Volume (min) Intensity (%HRres)
1–2 2–2:30 85 17:30 65 2–2:30 85 17:30 65
3–4 3–3:30 85 21:30 65 3–3:30 85 16:30 65
5–6 4–4:30 90 25:30 70 4 90 16 70
7–8 5–5:30 90 29:30 70 4 90 16 70
9–10 6–6:30 95 33:30 75 4 95 16 75
11–12 7–7:30 95 32:30 75 4 95 16 75
13–16 8 95 32 75 4 95 16 75
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study of coronary artery disease [49]. Therefore, we as-
sume a mean change of 5.0 mL kg−1 min−1 and a com-
mon standard deviation (SD) of 4.0 for participants
allocated to the HIIT groups and a mean change of 3.0 ±
4.0 mL kg−1 min−1 for participants allocated to the AC
group. Based on 1:1:1 randomization to three treatment
arms with equal group size, we expect that pre-post
intervention differences in our design would be achieved
with 177 people (59 each group, α = 0.05, Cohen
medium effect size f = 0.23, 80% power). Assuming a
maximum loss of follow-up of 10%, the plan will be to
recruit a total of 194 individuals. The statistical analysis
will be performed using IBM SPSS Statistics, Version
22.0 (IBM Corp., Armonk, NY, USA). In the final ana-
lysis, four comparisons will be made: HIIT groups vs
AC; HV-HIIT vs LV-HIIT; HV-HIIT vs AC; and LV-
HITT vs AC. Two parametric tests will be performed
after all assumptions for each test are met. For compari-
sons between groups at baseline, one-way analysis of
variance (ANOVA) or the non-parametric method of
Kruskal–Wallis and Chi-square test will be used. A lin-
ear regression model with ANOVA will be used to assess
training effects on the primary and secondary study out-
comes. We will examine the delta (Δ) score for each
group (AC, HV-HIIT, LV-HIIT), adjusting for age, sex,
changes in body mass, and the initial value of each of
the dependent variables. Helmert contrasts will be per-
formed to analyze the difference between the two exer-
cise groups pooled together and the AC group.
Bonferroni correction was used to determine the level of
significance when a significant main effect was found.
The differences between dropouts and participants who
remain in the study will be examined; the data will be
analyzed according to the intention-to-treat principle
[50]. For each outcome variable, the effect size and the
level of significance corresponding to the main group
(between-subjects), time (within-subjects), and inter-
action (group × time) will be reported. To prevent type I
error, post hoc comparisons (pre vs post by group) will
be performed when a significant interaction effect is
present. Values will be expressed as mean ± SD. The sig-
nificance level will be set at 5% (α = 0.05). Practical sig-
nificance will be assessed by calculating Cohen’s d effect
size. Effect sizes (d) > 0.8, in the range of 0.5–0.8, in the
range of 0.2–0.5, and < 0.2 will be considered as large,
moderate, small, and trivial, respectively.
Discussion
A large-scale national Swedish registry study showed
that the risk of cardiovascular events remained high in
the first year post MI, indicating that those patients
should be managed with effective prevention programs
[51]. Therefore, one of the main challenges in secondary
prevention after MI is the reduction in mortality and
morbidity through evidence-based interventions [7]. In
patients with stable angina pectoris secondary to coron-
ary atherosclerosis, the review found that interval train-
ing improved cardiorespiratory fitness, endothelial and
ventricular function, and morphology to a greater degree
than conventional light- to moderate- and moderate- to
high-intensity continuous aerobic training [9]. On the
other hand, less is known regarding the effects of LV-
HIIT, but growing evidence suggests this type of training
stimulates physiological remodeling comparable with
moderate-intensity continuous training despite a sub-
stantially lower exercise volume [17]. A recent study has
shown that LV-HIIT exercise elicits similar cytokine and
oxidative stress responses to steady-state at a high inten-
sity higher volume exercise [52]. However, based on the
review of the literature, several issues are still open to
question and would benefit from further investigation in
MI population:
– Does LV-HIIT provide similar benefits compared
to HV-HIIT and is it associated with a lower risk
of all-cause mortality in population after MI, being
able to confirm that “less is more”?
– Which combination of treatment (Mediet
recommendations + physical activity
recommendation vs Mediet recommendations +
supervised exercise) is most valuable in reducing
cardiovascular risk in patients after MI?
The increase in the prevalence of heart disease and re-
lated co-morbidities is often associated with polypharmacy
and disabilities, such as physical and emotional frailty.
Non-pharmacologic management strategies including
regular exercise and a healthy diet are necessary to get a
comprehensive care plan for the whole disease. This study
will be the first clinical trial comparing the effects of two
different volumes of HIIT programs with Mediet recom-
mendations for people after MI and also compared to an
attention control group receiving only recommendations.
The results of this trial will provide good evidence for
physical rehabilitation in this population and what type of
treatment achieves better physical results.
Trial status
Recruitment for the trial is finishing at the time of
submission.
Additional file
Additional file 1: SPIRIT 2013 Checklist: Recommended items to address
in a clinical trial protocol and related documents. (DOC 121 kb)
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